Trial Outcomes & Findings for Walking Aids in the Management of Hip Osteoarthritis (NCT NCT00506714)

NCT ID: NCT00506714

Last Updated: 2012-10-04

Results Overview

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

26 participants

Primary outcome timeframe

Baseline

Results posted on

2012-10-04

Participant Flow

Participant milestones

Participant milestones
Measure
Group 1
Healthy adults
Group 2
Adults with symptomatic hip osteoarthritis
Overall Study
STARTED
13
13
Overall Study
COMPLETED
13
13
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Walking Aids in the Management of Hip Osteoarthritis

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Group 1
n=13 Participants
Healthy adults
Group 2
n=13 Participants
Adults with symptomatic hip osteoarthritis
Total
n=26 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
6 Participants
n=5 Participants
5 Participants
n=7 Participants
11 Participants
n=5 Participants
Age, Categorical
>=65 years
7 Participants
n=5 Participants
8 Participants
n=7 Participants
15 Participants
n=5 Participants
Age Continuous
65 years
STANDARD_DEVIATION 4.4 • n=5 Participants
67 years
STANDARD_DEVIATION 5.9 • n=7 Participants
66 years
STANDARD_DEVIATION 5.2 • n=5 Participants
Sex: Female, Male
Female
2 Participants
n=5 Participants
2 Participants
n=7 Participants
4 Participants
n=5 Participants
Sex: Female, Male
Male
11 Participants
n=5 Participants
11 Participants
n=7 Participants
22 Participants
n=5 Participants
Region of Enrollment
United States
13 participants
n=5 Participants
13 participants
n=7 Participants
26 participants
n=5 Participants

PRIMARY outcome

Timeframe: Baseline

Population: Analysis was per protocol

Outcome measures

Outcome measures
Measure
Group 1
n=13 Participants
Healthy adults walking without a cane at baseline
Group 2
n=13 Participants
Adults with symptomatic hip osteoarthritis walking without a cane at baseline
Gait Velocity
107.5 cm/s
Standard Deviation 14.3
79.7 cm/s
Standard Deviation 9.9

SECONDARY outcome

Timeframe: Baseline

Population: Analysis was per protocol

Measured gait velocity when hip OA subjects walked with a cane at the baseline visit.

Outcome measures

Outcome measures
Measure
Group 1
n=13 Participants
Healthy adults walking without a cane at baseline
Group 2
Adults with symptomatic hip osteoarthritis walking without a cane at baseline
Gait Velocity With a Cane in Hip OA Subjects
68.7 cm/s
Standard Deviation 15.4

SECONDARY outcome

Timeframe: 4 weeks

Population: Analysis was per protocol

Gait velocity when adults with symptomatic hip osteoarthritis walked with a cane after four weeks of cane use

Outcome measures

Outcome measures
Measure
Group 1
n=13 Participants
Healthy adults walking without a cane at baseline
Group 2
Adults with symptomatic hip osteoarthritis walking without a cane at baseline
Gait Velocity
74.5 cm/s
Standard Deviation 14.2

Adverse Events

Group 1

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Group 2

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Meika A. Fang, MD

Arthritis Foundation

Phone: 310-478-3711

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place